FindTrial
Sign In

Effect of general anesthesia on the efficacy, therapeutic response and adverse reactions of Hemoporfin photodynamic therapy in the treatment of port wine stains: a propensity score matched-retrospective study

Effect of general anesthesia on the efficacy, therapeutic response and adverse reactions of Hemoporfin photodynamic therapy in the treatment of port wine stains: a propensity score matched-retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047966
Enrollment
Unknown
Registered
2021-06-28
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

port-wine stain

Interventions

Group 1:general anesthesia
Group 2:without general anesthesia

Sponsors

Wuhan 1st Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with port-wine stains treated with Hemporfin photodynamic therapy in the Department of Dermatology, Wuhan First Hospital from April 1, 2018 to May 30, 2021.

Exclusion criteria

Exclusion criteria: Patients who did not return to the hospital for follow-up visits 8-12 weeks after the first hemporfin photodynamic therapy treatment.

Design outcomes

Primary

MeasureTime frame
total effect rate;nearly recovery rate;effective rate;—

Secondary

MeasureTime frame
treatment reaction;—

Countries

China

Contacts

Public ContactLi Dongsheng

Wuhan 1st Hospital

LDS1204@126.com+86 27 85332176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026